1. Home
  2. NTWK vs QTTB Comparison

NTWK vs QTTB Comparison

Compare NTWK & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSol Technologies Inc.

NTWK

NetSol Technologies Inc.

HOLD

Current Price

$3.33

Market Cap

38.0M

Sector

Technology

ML Signal

HOLD

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$4.69

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTWK
QTTB
Founded
1997
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.0M
44.3M
IPO Year
1997
2018

Fundamental Metrics

Financial Performance
Metric
NTWK
QTTB
Price
$3.33
$4.69
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
51.8K
150.5K
Earning Date
05-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
316.67
N/A
EPS
N/A
N/A
Revenue
$73,088,687.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.40
100.00
52 Week Low
$2.14
$1.38
52 Week High
$5.75
$6.37

Technical Indicators

Market Signals
Indicator
NTWK
QTTB
Relative Strength Index (RSI) 52.38 57.02
Support Level $3.06 $3.99
Resistance Level $3.45 $4.36
Average True Range (ATR) 0.34 0.40
MACD -0.00 -0.00
Stochastic Oscillator 28.18 62.50

Price Performance

Historical Comparison
NTWK
QTTB

About NTWK NetSol Technologies Inc.

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

Share on Social Networks: